ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Deferasirox-Mepha 180 mg, Lactab - 30
67678003 Mepha Pharma AG
Deferasirox-Mepha 180 mg, Lactab24.08.2020
Generic24.08.2020
Deferasirox (V03AC03) 
WHO-DDD 
06.99.30
06.99. 
B  
Yes 
IP 
235.19Yes
    
10 %272.20
  
7680676780036Synthetika
  
Composition
deferasiroxum 180 mg, crospovidonum, cellulosum microcristallinum, poloxamerum 188, povidonum K 30, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 4000, E 132, talcum, pro compresso obducto.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
Deferasirox180 mg
BAG: Active AgentDose
Deferasirox180 mg
 
Inactive agentsDoseadditional_information
Cellulosum Microcristallinum  
Crospovidonum  
E 132 color.
E 171 color.
Hypromellosum Überzug
Macrogol4000  
Magnesii Stearas  
Poloxamer188  
Povidonum K30  
Pro Compresso Obducto  
Silica Colloidalis Anhydrica  
Talcum  
 
Source
Data was imported : 12.03.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home